Fabrazyme
AGALSIDASE BETA
- Strength
- 5 mg/mL
- Form
- Injection, Powder, Lyophilized, For Solution
- Class
- Hydrolytic Lysosomal Neutral Glycosphin…
Genzyme Corporation
Not stocked by us — reference only
AGALSIDASE BETA
Listed by Genzyme Corporation
| Dosage form | Injection, Powder, Lyophilized, For Solution |
|---|---|
| Route | Intravenous |
| Drug class | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme |
| Approval route | BLA — biologic licence |
| NDC code | 58468-0040 |
| FDA application | BLA103979 |
| RxNorm concept | 1804755 |
| Package sizes listed | 1 |
| Marketed since | December 2008 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
AGALSIDASE BETA
Genzyme Corporation
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.